Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerBilling CodesProprietary Laboratory AnalysesCPT cpt-0570u-istat-tbi-gfap-uch-l1-brain-injury-biomarker
    Ask Trek AI about this page

    CPT 0570U: i–STAT TBI GFAP and UCH–L1 Biomarker Test

    CPT code 0570U is a Proprietary Laboratory Analyses (PLA) code reported only for the Abbott Point of Care i–STAT TBI test that measures blood or plasma levels of glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl–terminal hydrolase L1 (UCH–L1); results are reported individually and combined into an overall elevated vs nonelevated determination. Service type: laboratory testing of blood or plasma; typical site of service: clinical laboratory or point-of-care/urgent care settings where the i–STAT platform is used for evaluation of suspected brain injury.

    For related coverage guidance, see recent payer policy updates: Expanded Molecular Testing for Infectious Disease Pathogens in the Outpatient Setting, Minimal Residual Disease (MRD) Testing for Cancer, Biomarker Testing Mandate.

    Customize your policy alerts

    Sign up for cpt 0570U policy alerts

    Get alerted when payer policies referencing 0570U are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Table of contents

    Progress1 / 7

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical & Coding Specifications

    Clinical Context

    A typical patient scenario involves an adult or adolescent presenting to the emergency department after a head trauma such as a fall, motor vehicle collision, sports injury, or assault. The patient has a mechanism concerning for traumatic brain injury (TBI) but has a noncontrast head CT that is normal or is being considered for CT decision support. The treating clinician orders the Abbott i-STAT TBI blood test to measure GFAP and UCH-L1 from a venous or plasma sample. Results report individual biomarker values and a combined interpretation of elevated or nonelevated based on the manufacturer's threshold. The workflow includes venipuncture or plasma draw, immediate point-of-care or central lab analysis using the proprietary i-STAT platform, documentation of the combined result in the chart, and integration of the result into clinical decision-making about CT imaging, observation, or discharge. Typical sites of service are the emergency department, urgent care centers, and hospital observation units. Service type: Proprietary Laboratory Analysis (PLA) — point-of-care or centralized lab proprietary assay.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    0570Ui-STAT TBI (Abbott) — GFAP and UCH-L1 assay, results reported individually and combined as elevated/nonelevatedPrimary PLA code for the proprietary assay described; report when using Abbott i-STAT TBI platform.
    36415Collection of venous blood by venipunctureCommonly performed immediately prior to sending blood for the GFAP/UCH-L1 assay; billed for specimen collection when reportable.
    85025Blood count; CBC with automated differentialOften ordered concurrently in head trauma workups to assess overall physiologic status, though not directly part of the PLA test.
    70450CT head/brain without contrastFrequently performed before or after biomarker testing to evaluate for intracranial hemorrhage; biomarker results may influence decision to obtain CT.
    87086Culture, bacterial; quantitative colony count (example lab code)Data not directly related to this PLA test but represents typical ancillary lab code types; include only when microbiology testing is performed concurrently.
    96372Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscularRepresents possible adjunctive interventions (eg, analgesia) during ED evaluation; may occur in same encounter but is not directly related to the PLA assay.

    Related Modifiers

    8 rows

    ModifierDescriptionWhen to Use
    22Modifier –22 (Increased Procedural Services) is used when a reported procedure is substantially more extensive than normally required. The CPT Manual and CMS state it may be appended only when the…- When to use: Append modifier -22 to a procedural CPT code when the service performed is substantially more extensive than the usual service described by that code — i.e., the procedure required…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    76Modifier -76, Repeat Procedure or Service by Same Physician or Other Qualified Health Care Professional, is appended when the same provider performs an identical, medically necessary procedure or…- Use modifier -76 when the same physician or other qualified health care professional performs an identical procedure or service a second (or subsequent) time on the same date of service and the…
    77Modifier 77 indicates that a previously performed procedure or service was legitimately repeated by a different physician or other qualified health care professional. The AMA’s CPT definition…- Use modifier 77 when a basic procedure or service already performed is repeated by a different physician or other qualified health care professional (for example, a second provider independently…
    90Modifier ‑90 (Reference/Outside Laboratory) indicates that a laboratory test was performed by an entity other than the treating or reporting provider. The American Medical Association defines…- Use CPT modifier -90 when a laboratory test is performed by an outside/reference laboratory (an entity other than the treating or reporting physician or qualified professional) and the claim needs…
    91Modifier 91 — “Repeat Clinical Diagnostic Laboratory Test” — is appended when the exact same CPT laboratory test is performed more than once for the same patient on the same day because serial,…- Use modifier 91 when the exact same CPT laboratory test is performed more than once on the same patient on the same date because serial or repeated testing is medically necessary to monitor…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    2084P0800X
    208D00000X
    207RR0500X
    164X00000X
    207XS0114X
    163WI0600X
    246ZN0300X
    103TE1000X

    Related ICD-10-CM Codes

    25 rows

    ICD-10-CM CodeDescription
    F07.0Personality change due to known physiological condition
    F07.81Postconcussional syndrome
    G44.209Tension-type headache, unspecified, not intractable
    G93.6Cerebral edema
    H81.13Benign paroxysmal vertigo, bilateral
    R41.0Disorientation, unspecified
    R41.3Other amnesia
    R42Dizziness and giddiness
    S01.00XAUnspecified open wound of scalp, initial encounter
    S01.91XALaceration without foreign body of unspecified part of head, initial encounter

    Showing 1–10 of 25

    Related Payer Policy Updates

    Specialty: Genetic & Molecular Testing1 / 3

    10 rows

    PolicyPayerEffective Date
    Expanded Molecular Testing for Infectious Disease Pathogens in the Outpatient Settinguniverahealthcare2027-02-15
    Minimal Residual Disease (MRD) Testing for Cancerregence2027-01-01
    Biomarker Testing MandateBlue Cross Blue Shield - Rhode Island2027-01-01
    Prenatal (Fetal) Diagnostic TestingBlue Cross Blue Shield - Rhode Island2027-01-01
    Oral Cancer Screening and TestingOscar Health2027-01-01
    RTM Testing for Alpha-1 Antitrypsin DeficiencyOscar Health2027-01-01
    Cytochrome P450 Genotype-Guided Treatment Strategy Corporate Medical Policybcbsvermont2027-01-01
    Cytochrome P450 Genotypingblue cross blue shield - tennessee2026-12-31
    Polygenic Risk ScoreBlue Cross Blue Shield - Rhode Island2026-12-01
    Gene Expression Profiling for Cutaneous MelanomaBlue Cross Blue Shield - Rhode Island2026-12-01

    Related Codes

    CPT-0001U-PRECISETYPE-HEA-MULTIPLEX-RBC-ANTIGEN-GENOTYPING

    CPT 0001U: PreciseType HEA Erythrocyte Antigen Genotyping

    CPT-0002U-POLYPDX-URINE-METABOLOMIC-ASSAY-ADENOMATOUS-POLYP-RISK

    CPT 0002U: PolypDX™ Urine Metabolomic Risk Assay

    CPT-0003U-OVAR-A-NEXT-GENERATION-OVARIAN-CANCER-RISK-ASSAY

    CPT 0003U: Overa (MIA2G) Ovarian Cancer Risk Assay

    CPT-0005U-PROSTATE-EXOSOMEDX-INTELLISCORE-GENE-EXPRESSION-URINE-TEST

    CPT 0005U: ExosomeDx Prostate (IntelliScore) urine gene expression test

    CPT-0007U-TOXPROTECT-URINE-DRUG-SCREEN-WITH-DNA-AUTHENTICATION

    CPT 0007U: ToxProtect Urine Drug Screen With DNA Authentication

    CPT-0008U-H-PYLORI-ANTIBIOTIC-RESISTANCE-SEQUENCING-PANEL

    CPT 0008U: H. pylori Antibiotic Resistance Gene Panel

    CPT-0009U-DEPARRAY-HER2-FISH-TUMOR-CELL-ISOLATION

    CPT 0009U: DEPArray HER2 Tumor‑Cell Isolation with FISH Analysis

    CPT-0010U-BACTERIAL-TYPING-WHOLE-GENOME-SEQUENCING-MAYO-CLINIC

    CPT 0010U: Bacterial Typing by Whole Genome Sequencing, Mayo Clinic

    CPT-0011U-CORDANT-CORE-ALGORITHMIC-ORAL-FLUID-DRUG-TEST

    CPT 0011U: Oral Fluid Drug Test with Algorithmic Steady‑State Comparison

    CPT-0016U-BCR-ABL1-MAJOR-MINOR-FUSION-TRANSCRIPT-TESTING

    CPT 0016U: BCR–ABL1 Major and Minor Breakpoint Fusion Transcripts

    Showing 1–10 of 536

    • More pages

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.